Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 219

1.

Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol.

Smulevich AB, Khanna S, Eerdekens M, Karcher K, Kramer M, Grossman F.

Eur Neuropsychopharmacol. 2005 Jan;15(1):75-84.

PMID:
15572276
2.

An open-label extension trial of risperidone monotherapy in the treatment of bipolar I disorder.

Hirschfeld RM, Eerdekens M, Kalali AH, Canuso CM, Khan AA, Karcher K, Palumbo JM.

Int Clin Psychopharmacol. 2006 Jan;21(1):11-20.

PMID:
16317312
3.

Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.

Sheehan DV, McElroy SL, Harnett-Sheehan K, Keck PE Jr, Janavs J, Rogers J, Gonzalez R, Shivakumar G, Suppes T.

J Affect Disord. 2009 Jun;115(3):376-85. doi: 10.1016/j.jad.2008.10.005.

PMID:
19042026
4.

Risperidone in the treatment of acute mania: double-blind, placebo-controlled study.

Khanna S, Vieta E, Lyons B, Grossman F, Eerdekens M, Kramer M.

Br J Psychiatry. 2005 Sep;187:229-34.

5.

Risperidone in combination with mood stabilizers: a 10-week continuation phase study in bipolar I disorder.

Bowden CL, Myers JE, Grossman F, Xie Y.

J Clin Psychiatry. 2004 May;65(5):707-14.

PMID:
15163260
6.

Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial.

Akhondzadeh S, Milajerdi MR, Amini H, Tehrani-Doost M.

Bipolar Disord. 2006 Oct;8(5 Pt 1):485-9.

PMID:
17042886
7.

Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial.

Yatham LN, Grossman F, Augustyns I, Vieta E, Ravindran A.

Br J Psychiatry. 2003 Feb;182:141-7. Erratum in: Br J Psychiatry. 2003 Apr;182:369.

8.

Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study.

Haas M, Delbello MP, Pandina G, Kushner S, Van Hove I, Augustyns I, Quiroz J, Kusumakar V.

Bipolar Disord. 2009 Nov;11(7):687-700. doi: 10.1111/j.1399-5618.2009.00750.x.

PMID:
19839994
9.

A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder.

Bowden CL, Grunze H, Mullen J, Brecher M, Paulsson B, Jones M, Vågerö M, Svensson K.

J Clin Psychiatry. 2005 Jan;66(1):111-21.

PMID:
15669897
10.

Acute and continuation risperidone monotherapy in mania.

Vieta E, Brugué E, Goikolea JM, Sánchez-Moreno J, Reinares M, Comes M, Colom F, Martínez-Arán A, Benabarre A, Torrent C.

Hum Psychopharmacol. 2004 Jan;19(1):41-5.

PMID:
14716711
11.

Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial.

Segal J, Berk M, Brook S.

Clin Neuropharmacol. 1998 May-Jun;21(3):176-80.

PMID:
9617509
12.
14.
15.
16.

Efficacy and safety of combination of risperidone and haloperidol with divalproate in patients with acute mania.

Ouyang WC, Hsu MC, Yeh IN, Kuo CC.

Int J Psychiatry Clin Pract. 2012 Sep;16(3):178-88. doi: 10.3109/13651501.2011.644564.

PMID:
22404731
17.

Quetiapine or haloperidol as monotherapy for bipolar mania--a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial.

McIntyre RS, Brecher M, Paulsson B, Huizar K, Mullen J.

Eur Neuropsychopharmacol. 2005 Oct;15(5):573-85.

PMID:
16139175
18.

Risperidone in acute and continuation treatment of mania.

Yatham LN, Binder C, Riccardelli R, Leblanc J, Connolly M, Kusumakar V; RIS-CAN 25 Study Group..

Int Clin Psychopharmacol. 2003 Jul;18(4):227-35.

PMID:
12817157
19.
20.

A double-blind, randomized, prospective evaluation of the efficacy and safety of risperidone versus haloperidol in the treatment of schizoaffective disorder.

Janicak PG, Keck PE Jr, Davis JM, Kasckow JW, Tugrul K, Dowd SM, Strong J, Sharma RP, Strakowski SM.

J Clin Psychopharmacol. 2001 Aug;21(4):360-8.

PMID:
11476119
Items per page

Supplemental Content

Support Center